Production of Medical Radionuclides in the Center for Radiopharmaceutical Tumor Research—A Status Report

oleh: Martin Kreller, Santiago Andrés Brühlmann, Torsten Knieß, Klaus Kopka, Martin Walther

Format: Article
Diterbitkan: MDPI AG 2024-02-01

Deskripsi

A new Center for Radiopharmaceutical Cancer Research was established at the Helmholtz-Zentrum Dresden-Rossendorf in 2017 to centralize radionuclide and radiopharmaceutical production, as well as enable chemical and biochemical research. Routine production of several radionuclides was put into operation in recent years. We report on the production methods of radiopharmaceutical radionuclides, in particular <sup>11</sup>C, <sup>18</sup>F, and radio metals like <sup>61</sup>Cu, <sup>64</sup>Cu, <sup>67</sup>Cu, <sup>67</sup>Ga, <sup>131</sup>Ba, and <sup>133</sup>La that are used regularly. In the discussion, we report typical irradiation parameters and achieved saturation yields.